EXPLORE CONNECTIONS
Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod.
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.